Notably, based on ORR and survival, many studies in NSCLC patients have shown significant associations between the ERCC1 rs11615 variant and the efficacy of chemotherapy [37,41], but others have failed to find a correlation [23]. The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.